Send me a link:

*Text messaging rates may apply.

 Dow Up 0.13% Nasdaq Down 0.10%

Novogen Limited (NVGN)

-NCM
3.28 0.05(1.50%) Jul 28, 3:54PM EDT
Prev Close:3.33
Open:3.38
Bid:2.92 x 600
Ask:3.39 x 100
1y Target Est:N/A
Beta:-0.04
Next Earnings Date:N/A
Day's Range:3.24 - 3.39
52wk Range:3.09 - 6.84
Volume:6,268
Avg Vol (3m):31,818
Market Cap:21.19M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVGN

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):43.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novogen Limited operates as a pharmaceutical drug development company worldwide. It focuses on the development of a family of anti-cancer drugs based on super-benzopyran and stealth drug technologies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback